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Abstract
There is emerging evidence that transcranial magnetic stimulation (TMS) can produce analgesic
effects in clinical samples and in healthy adults undergoing experimentally induced pain, and the
field of minimally invasive brain stimulation for the management of pain is expanding rapidly.
While, motor cortex is the most widely used cortical target for TMS in the management of
neuropathic pain, few studies have systematically investigated the analgesic effects of a full range
of device parameters to provide initial hints about what stimulation intensities and frequencies are
most helpful (or even potentially harmful) to patients. Further, there is considerable inconsistency
between studies with respect to laboratory pain measurement procedures, TMS treatment
parameters, sophistication of the sham methods, and sample-sizes. The present study employed a
sham-controlled, within-subject, cross-over design to examine the effects of five different TMS
treatment parameters across several quantitative sensory measures in a sample of healthy adult
volunteers. 65 participants underwent quantitative sensory testing procedures pre- and post- 40-
minutes of real and sham motor cortex TMS. TMS was delivered at 1Hz 80% resting motor
threshold (rMT), 1Hz 100%rMT, 10Hz 80%rMT, 10Hz 100%rMT, or 50Hz triplets at 90% of
active motor threshold (intermittent theta-burst). The mean painfulness rating of real TMS
stimulation itself was 3.0 (SE=.36) out of 10 and was significantly greater than zero (t(64)=8.17,
p<.0001). The sham TMS methods used permitted matching between real and sham TMS-induced
scalp sensations and participants were successfully blinded to condition (real versus sham).
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Findings suggest that the effects of motor cortex TMS on quantitative sensory tests in healthy
adults vary across different treatment parameters with the smallest observed effect for intermittent
theta-burst stimulation (Cohen's d=0.03) and the largest for 10Hz 100%rMT (d=.34). Overall,
TMS was associated with statistically significant effects on warm and cool sensory thresholds,
cold pain thresholds, suprathreshold stimulus unpleasantness ratings and wind-up pain. With
respect to device parameter effects, higher frequency stimulation appears to be associated with the
most analgesic and anti-sensitivity effects with the exception of intermittent theta-burst
stimulation. The present findings support several clinical research findings suggesting that higher
TMS frequencies tend to be associated with the most clinical benefit in patients with chronic pain.
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Introduction
Transcrianial magnetic stimulation (TMS) is a minimally invasive brain stimulation
technology that can focally stimulate the brain of an awake individual [1,2]. A localized
pulsed magnetic field transmitted through a figure-8 coil (lasting only microseconds) is able
to focally stimulate the cortex by inducing electrical currents in the brain [3] that depolarize
superficial (a few millimeters deep) cortical neurons [4,5].
Medium-term effects of TMS (seconds to minutes) likely arise from transient changes in
local neurochemistry[6] and a great deal of research has been focused on whether different
TMS frequencies might have different biological effects. Repeated lower-frequency
stimulation of a single neuron in culture can produce long-lasting inhibition of cell-cell
communication, while higher frequency stimulation can improve communication [7].
Several studies have shown that chronic stimulation of the motor cortex can produce
inhibitory or excitatory intermediate effects that last several minutes following stimulation
[8,9].
There is accumulating evidence that TMS can produce analgesic effects in chronic pain
conditions of various etiologies, reduce post-operative pain, and decrease laboratory-induced
pain in healthy adult samples [10–40]. While some early research in this area seemed to
indicate that TMS was only capable of producing short-lived effects, more recent evidence
suggests that repeated TMS treatments can produce meaningful analgesic effects lasting
several weeks [15,30,38] if delivered repeatedly for days to weeks. Various cortical targets
have been investigated, but the results of most studies to date support the utility of motor
cortex stimulation, especially for neuropathic pain [19,32–36,41]. The field of minimally
invasive brain stimulation for the management of pain is expanding rapidly, and researchers
have moved quickly into the clinical arena without accumulating much preliminary data
regarding the most effective device parameters for managing clinical pain. While, motor
cortex is the most widely used cortical target for TMS in the management of neuropathic
pain, few studies have systematically investigated the analgesic effects of a full range of
device parameters to provide initial hints about what stimulation intensities and frequencies
are most helpful (or even potentially harmful) to patients.
Some recent findings suggest that the analgesic effects of motor cortex stimulation may be
due in part to changes in activity at local cortical sites as well as at the thalamic nuclei [42].
It is possible that corticothalamic tracts may exert an inhibitory influence on thalamic pain
processing and transmission [29]. High frequency rTMS may suppress pain information
relayed through the spinothalamic tracts and the ipsilateral thalamic nuclei [33,36,37].
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However, there is also evidence to suggest that at least a portion of motor-cortex TMS-
related analgesic effects may be due to changes in prefrontal and limbic activity (associated
with the affective and cognitive-evaluative dimensions of pain experience) [33,34,43].
While there are some promising findings in this literature, there is much variability with
respect to the: (1) number of TMS pulses delivered per study, (2) frequency of the rTMS
pulses, (3) intensity of the TMS stimulation, (4) duration of the treatment, (5) sham TMS
methods, and (6) dependent measures used [43]. Recent meta-analytic and review studies
suggest that at least 1000 to 1200 TMS pulses are needed to realize analgesic efficacy and
repeated TMS sessions are associated with longer-term effects [43,44]. There is also
evidence to suggest that higher frequency and intensity stimulation may be better for clinical
applications [32,44], but the range of TMS frequency in the current clinical and laboratory
research literature is large (0.5Hz to 20Hz, and in some studies 50Hz triplets (theta-burst)
stimulation is used) [45]. The intensity of the stimulation varies considerably (80% of motor
threshold up to 120%)[45]. When sham-control conditions have been employed, methods
are often sub-optimal. TMS, especially at higher intensities and frequencies, can produce
scalp sensations. These sensations can be uncomfortable or even painful for some
individuals[41,44,46]. Unfortunately, many of the existing studies of TMS effects on pain
perception have not employed methods to simulate and match the sensations of sham
stimulation with active stimulation. However, there now exists technology to match sham
TMS sensations with those of real [47,48].
The present study was designed to address these issues and employed a sham-controlled,
within-subject, cross-over design to examine the effects of five different TMS treatment
conditions (controlling for total number of TMS pulses (1200 per session over two sessions)
and duration of stimulation) across a wide array of experimental pain-inducement methods
in a sample of healthy adult volunteers. The sham TMS methods were conducted in a
manner such that sham stimulation produced similar sensations to real stimulation.
Methods
Participants
Participants were 75 right-handed healthy volunteers with no history of chronic pain,
depression, anxiety, seizures, closed head injuries, or metal implants above the waist. Eight
participants did not complete both study visits (did not return follow-up scheduling phone
calls) and were excluded from analysis. Two participants had vasovagal syncope during the
motor threshold assessment and were excluded from the study. Sixty-five participants were
included in the analysis (39 females and 26 males). The mean age of the sample was 29.95
(SD=11.51). Two were Asian, 11 were African American, 2 were Hispanic and 50 were
Caucasian. Ten of the participants were smokers. This study was approved by the
Institutional Review Board at the home institution and all participants provided written
informed consent. All procedures were conducted in the Brain Stimulation Laboratory at the
Medical University of South Carolina.
Measures
Screening Measures—Participants completed the Beck Depression Inventory-II (BDI),
the Beck Anxiety Inventory (BAI), and the Brief Pain Inventory (BPI) and were eligible for
the study if their BDI scores were less than 12, their BAI scores were less than 12 and if
they reported no history of chronic pain conditions.
Hot and Cold Sensory Threshold Assessment—The Medoc PATHWAY Pain &
Sensory Evaluation System (Medoc Ltd, Israel) with advanced thermal stimulator (ATS)
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was used to apply 10 thermal stimuli to participants' left volar forearm, 5cm from the wrist.
The thermal baseline temperature was set to 32°C. The Medoc system randomized the order
of stimuli (5 warm and 5 cold) as well as the duration of the rest period between stimuli. At
the start of each trial, the thermode increased or decreased in temperature at the rate of
0.25°C per second and participants were instructed to push a button the moment they
detected any change in temperature. After participants pressed the button, the thermode
returned to baseline temperature and the next trial began (with a random interstimulus
interval ranging from 1 to 5 seconds).
Hot and Cold Pain Threshold Assessment—The Medoc PATHWAY system with
ATS thermode was used to apply 10 thermal stimuli to each participant's left volar forearm,
5cm from the wrist. The thermal baseline temperature was set to 32°C and the program
alternated between hot and cold stimuli. The thermode was programmed to increase or
decrease from baseline at the rate of 1°C per second and participants were instructed to press
a button when the sensation reached “the level that they considered to be painful.” They
were further instructed “We are not interested in seeing how much you can tolerate or stand,
but rather we are interested in determining exactly what temperature you consider to be
painful, or stated another way, what exact temperature crosses your threshold from being hot
(or cold) to being painful.” After each trial, participants used a computerized visual analogue
scale (VAS) to rate the painfulness of each stimulus at its worst during the trial (anchored
with “no pain” and “worst pain imaginable”) so that we could determine whether changes in
pain threshold (if found) were due to changes in reaction time or a willingness to tolerate
more or less pain before stopping the ramping thermode. A 30-second rest period was used
between trials.
Mechanical Pain Threshold Assessment—A digital Electrovonfrey Anesthesiometer
(IITC model Alemo 2290-4; Woodland Hills, CA, USA) was used with rigid plastic tips.
Pressure was applied to the dorsum of the ventral pad of the digit minimi of the right hand at
the rate of 10 grams per second. Participants were instructed to say “stop” as soon as the
sensation reached the level they considered to be painful. They were further instructed “We
are not interested in seeing how much you can tolerate or stand, but rather we are interested
in determining exactly what pressure you consider to be painful, or stated another way, what
exact pressure crosses your threshold from pressure to pain.” After each trial, participants
used a computerized visual analogue scale (VAS) to rate the painfulness of the stimulus at
its worst during the trial (anchored with “no pain” and “worst pain imaginable”) so that we
could determine whether changes in pain threshold (if found) were due to changes in
reaction time or a willingness to tolerate more or less pain before stopping the application of
pressure. A 30-second rest period was used between trials.
Suprathreshold Magnitude Assessment—The Medoc PATHWAY system with
contact heat evoked potential stimulator (CHEPS) was used to apply brief (0.75 second)
thermal stimuli to the left volar forearm, 5cm from the wrist. Stimuli were provided at 3
levels (46°C, 47.5°C and 49°C) and the order of presentation was random. Three stimuli
were presented for each temperature (9 trials). Participants rated the painfulness and
unpleasantness of each stimulus using the computerized VAS described above. A 30-second
rest period was used between trials.
Thermal Wind-Up Pain Assessment—The Medoc PATHWAY system with CHEPS
thermode was used to apply 30-seconds of brief (0.5 second) heat pulses delivered at the rate
of 1 per 1.5 seconds to the left volar forearm. Two practice trials were conducted using the
heat pain threshold determined via methods described above. The wind-up curve was
generated using the heat threshold plus 1.5°C. Participants rated the painfulness of the
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stimuli in real-time using a computerized VAS. The computerized VAS program recorded
the position of the VAS marker every second throughout each 30-second trial.
TMS Methods
Equipment—A Neuronetics (Model 2100, Neuronetics Inc.; Malvern, PA) was used to
deliver all TMS. An iron-core, soild-state figure of 8 coil was used. The eSham system [47]
was used in conjunction with a specially-design sham TMS coil from Neuronetics that
matched the real TMS coil in appearance as well as the sound it generated. When combined
with the eSham system, the sham TMS scalp sensations are able to be matched with the
sensations produced by real TMS (see Sham Control TMS methods below).
Motor threshold assessment—The TMS machine was set to 40% of maximal output
with a frequency of 0.5Hz and a systematic search strategy was implemented to localize the
area of the motor strip associated with visible movement of the abductor pollicis brevis
(APB) of the right hand. The machine intensity was adjusted until APB movement was
achieved and then localized. The coil location was marked with a nontoxic felt-tipped
marker on the participant's scalp for use during the motor threshold assessment and as the
rTMS treatment location. A computerized Parameter Estimation by Sequential Testing
(PEST) algorithm was used to estimate resting motor threshold with visual thumb movement
as the criteria[49]. If the participant was assigned to the theta-burst condition (see Treatment
Conditions below), an analogue hand dynomometer was used and participants applied active
pressure to the device at 20% of maximal force during TMS pulses (visual detection of
dynomometer needle movement was used as the criterion). The PEST seed vale was
determined by the TMS administrator based on the best guess of the true threshold using
information obtained during the localization process [49].
Treatment conditions—Participants were randomly assigned to one of 5 treatment
conditions (1Hz at 80%rMT [n=13], 1Hz at 100%rMT [n=12], 10Hz, at 80%rMT [n=15],
10Hz at 100%rMT [n=13], theta-burst (50 Hz triplets delivered at the rate of 5Hz) at 90% of
active motor threshold [n=12]). Participants received two 20-minute motor rTMS sessions
per visit (separated by a 20 minute rest period) in order to ensure adequate TMS dosing to
produce effects (if present) and to better approximate dosing strategies used in clinical
treatments than previous laboratory studies. Total number of pulses per session was set to
1200 and on/off times were adjusted to maintain this standard. For 1Hz conditions,
participants received 1 pulse per second for 20 minutes (no off-time). For 10Hz conditions,
participants received 20-minutes of TMS (10 pulses per second) with a 4-second on-time
and 36-second off-time. For theta-burst, participants received 2 seconds of 50Hz triplets
delivered at the rate of 5 triplets per second and an off-time of 28-seconds. Thus, in all
conditions, participants received a total of 2400 pulses at each visit.
Participants completed two visits and were randomly assigned to receive real rTMS at one
visit and sham rTMS at the other. The methods employed at each visit were identical except
for whether real or sham stimulation occurred.
Sham (Control) TMS methods—The eSham system[47] was implemented in
conjunction with the specialized Neuronetics sham TMS coil. Two Thymapad Stimulus
Electrodes (Somatics, LLC; Lake Bluff, Il) were placed on the scalp under the TMS coil
separated by 1cm. For conditions involving 100%rMT, an additional 2 thymapad electrodes
(connected to the electrical generator from the eSham system) were placed across the APB
of the right hand. The electrodes were attached to the hand during both real and sham
conditions. If during the sham titration procedures, stimulation produced visible movement
of the hand, the generator was set to deliver TMS-synced pulses of mild electrical current
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during the sham treatment in order to create subtle thumb movement so that participants
would be unable to determine whether they were receiving real or sham stimulation based
on whether they experienced movement. In most cases, movement was not noticed in the
100%rMT conditions (likely due to slight decreases in cortical excitability induced by the
sham titration TMS pulses; see below) and thus the generator was only connected for 2
subjects in the 1Hz condition and 1 in the 10Hz condition (a total of 3 out of 65; 4.6% of
participants study-wide) where TMS motor movement was deemed problematic with respect
to maintaining the blind.
Next, 1-second (3-seconds if the participant was to receive 1Hz stimulation) of stimulation
was applied at the frequency assigned to the participant. However, the intensity was pseudo-
randomly varied around the actual intensity to be delivered during the treatment session.
These brief trains were interspersed with identical sham TMS trains with pseudo-randomly
varying mA values from the eSham electrical generator. Participants were asked to rate the
painfulness of each stimulation train using a numeric rating scale (0=no pain at all, 10=worst
pain imaginable). This procedure continued until the mA value of electrical stimulator was
determined that produced identical subjective pain ratings to those of the real stimulation at
the TMS intensity to which the participant was assigned.
Procedures
Participants completed all screening measures and provided written informed consent to
participate. They were then taken to the laboratory and quantitative sensory testing was
conducted. The order of the pain measurement procedures was randomized except that the
thermal sensory threshold trials were always conducted first, followed by pain threshold
assessment in order to provide the temperatures necessary for conducting the wind-up trials.
The thermode was always placed on the same spot on the left arm for each participant.
After completion of the quantitative sensory assessment, a TMS motor threshold was
obtained. The eSham system was set-up and titrated to match the cutaneous sensations
associated with real TMS at the intensity and frequency to be delivered during the rTMS
session. If motor movement was noticed in the 100%rMT conditions toward the end of the
titration procedures, the eSham electrical generator was routed to mimic this movement
during sham stimulation sessions (n=3). Participants underwent two 20-minute motor rTMS
sessions separated by a 20-minute break, and then completed another quantitative sensory
assessment. Participants came back to the laboratory 2-weeks later and underwent the exact
same procedures except that if they received real TMS at the first visit, they received sham
at the second visit (and vice versa). The same stimulation parameters were used for the real
and sham TMS sessions at visit-one and visit-two. After completion of the second visit,
participants were asked to guess which session was real and which was sham as well as
provide a confidence rating using a numeric rating scale.
Analyses
For all sensory and pain threshold measurements, the first of the five trials in each series was
discarded to control for novelty effects, and to reduce variability associated with suppression
of a-∂ fiber activity to ensure consistency between the subsequent measured trials [50].
Hierarchical Linear Modeling (HLM) was implemented using PROC MIXED in SAS (SAS
Institute Inc.; Cary, NC) in order to assess the within-subject interactions of time (pre to post
TMS) and treatment type (real versus sham TMS) and the between-subject factor of TMS
device-parameter condition (1Hz at 80%rMT, 1Hz at 100%rMT, 10Hz at 80%rMT, 10Hz at
100%rMT, theta-burst at 90%aMT), on quantitative sensory measurements (thereby by
testing a series of 2×2×5 full factorial mixed models) [51] [52]. Prior to application of the
models, baseline scores (pre-TMS) were evaluated between groups (real versus sham) and
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between the 5 TMS treatment conditions. If significant baseline differences were observed
for a quantitative sensory test, the baseline scores were co-varied in that model to control for
baseline differences (i.e., determine if there were any significant effects over-and-above
baseline differences). For all models, each individual threshold trial and suprathreshold
estimation trial for each subject was entered into the model and the means and slopes were
model-estimated at level-1 for each subject. Wind-up slopes were square-root transformed to
achieve linearity and HLM was used to examine differences in wind-up slopes as a function
of the Treatment Type × Time interaction and TMS-condition. Participants' individual
intercepts and slopes were entered into the model as random effects. The covariance
structure of the models was “unstructured”, the estimation method was restricted maximum
likelihood (REML), and the degrees of freedom estimation method was Kenward-Roger.
Subjective procedural pain ratings for real rTMS were examined using one-sample t-tests to
determine whether the TMS procedures resulted in any pain (i.e., pain ratings > 0) and to
substantiate the use of the eSham system (which was titrated to match the procedural
painfulness of real TMS for each participant individually).
Results
TMS Procedural Painfulness—The mean painfulness rating of real TMS stimulation
was 3.0 (SE=.36) out of 10 (where 0=“no pain” and 10=“worst pain imaginable”). This
mean painfulness rating was significantly greater than zero (t(64)=8.17, p<.0001). There was
some variability in the painfulness across the different TMS treatment settings. The most
painful TMS settings were 10Hz100% and theta-burst. TMS at 10Hz100% was associated
with a mean painfulness rating of 4.6 (SE=.88; t(12)=5.29, p=.002) and theta burst was
associated with a mean painfulness rating of 4.9 (SE=.81; t(11)=6.12, p=.001). TMS at
1Hz100% was associated with a mean painfulness rating of 2.3 (SE=.56; t(11)=4.03, p=.
005). The least painful conditions were the ones involving 80%rMT. TMS at 10Hz80% was
associated with a mean painfulness rating of 1.9 (SE=.63; t(14)=2.98, p=.018) and 1Hz80%
was associated with a mean rating of 1.8 (SE=.56; t(12)=3.13, p=.017).
Overall, the mean mA value used to match the sham TMS sensations with those of real TMS
was 2.81 mA (SE=0.28). The mean motor threshold value was 53.71% of machine output
(SE=1.65).
Mask Validity—With respect to guesses about whether participants received real or sham
TMS, 51% of the sample guessed correctly (X2(1)=0.019, ns) which is not significantly
different from chance, suggesting that participants were unable to determine correctly which
treatment was real and which was sham. The mean guess-confidence rating in the group that
guessed correctly was 5.04 out of 10 (SE=0.63) and the mean for the group that guessed
incorrectly was 5.98 (SE=0.67). These values were not significantly different (t(63)=1.03,
ns) suggesting that those guessing correctly were no more or less confident in their guess
than those guessing incorrectly.
Pain Threshold Task Validity—No significant main effects or interactions were found
for time (pre- to post- TMS), TMS type (real versus sham) or TMS condition on participants'
subjective appraisals of the level of painfulness associated with each of the pain threshold
trials (hot, cold and mechanical). Thus, if significant effects are detected for any of the pain
threshold trials, it is likely due to a change in the threshold itself, and not due to changes in
reaction time, task performance strategies, or other factors that might influence the
behavioral patterns associated with terminating each threshold stimulus during the
thresholding trial. Participants rated the mean painfulness achieved for each heat pain
threshold trial as 37.87 (SE=.66) out of 100 (where 0=no pain and 100=worst pain
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imaginable) suggesting that participants stopped the thermode from heating to indicate their
heat pain threshold was reached when the sensation was experienced as ~3.8 out of 10. The
mean subjective rating associated with the pain-level experienced during cold pain threshold
trials was 32.11 (SE=.67), and the mean subjective rating associated with mechanical pain
thresholding trials was 32.55 (SE=.64).
TMS and Device Parameter Effect Summary
The effect sizes (Cohen's d) across all pain modalities in this healthy adult cohort varied as a
function of TMS device parameters. The largest effect size was observed for 10Hz100%
rTMS (d=0.34). The smallest effect size was observed for theta-burst stimulation (d=.03).
The effect sizes for 1Hz100% and 1Hz80% settings were 0.24 and 0.32 respectively, and the
effect-size for 10Hz80% was 0.18.
Heat Sensory Thresholds
No significant baseline differences in heat sensory thresholds were observed between groups
(real versus sham TMS; F(1,459)=0.07, ns) nor across TMS treatment conditions
(F(4,51.7)=0.41, ns). There were no main effects on pre- post- TMS changes in heat sensory
threshold for real versus sham TMS (F(1,949)=0.29, ns), nor across TMS device setting
conditions (F(4,57)=0.30, ns). However, the pre-post × real-sham × device-parameter
interaction was significant (F(4,941)=3.76, p=.005), and 10Hz100% TMS was associated
with a significant increase in heat sensory threshold compared to sham (t(941)=3.14,
p=0.002). Similarly, 10Hz80% was associated with a significant increase in heat sensory
threshold relative to sham (t(943)=2.69, p=0.0073). No significant effects were observed for
the other TMS settings on heat sensory thresholds (see Table 1).
Cold Sensory Thresholds
No significant baseline difference in cold sensory thresholds were observed between groups
(real versus sham TMS; F(1,470)=0.00, ns) nor across TMS treatment conditions
(F(4,50.8)=1.22, ns). There was no main effect on pre- post- TMS changes in cold sensory
thresholds for real versus sham TMS (F(1,952)=0.01, ns), nor for TMS condition
(F(4,62.2)=1.28, ns). However, there was a significant three-way pre-post × real-sham ×
device-parameter interaction effect on cold sensory thresholds (F(4,936)=3.11, p=.015).
Real 10Hz100% rTMS was associated with a relative anti-hypersensitivity effect compared
to sham (t(936)=2.75, p=.006) and 10Hz80% was associated with an anti-hypersensitivity
effect (t(936)=2.37, p=.02) as well. No other TMS conditions were associated with
significant effects on cold sensory thresholds (see Table 1).
Heat Pain Thresholds
There was a significant difference in baseline scores between the real and sham conditions
(F(1,412)=15.05, p<.0001), but no difference across TMS conditions (F(4,60.4)=0.12, ns).
After controlling for baseline differences, there was a significant main effect on pre- post-
TMS changes in heat pain thresholds for real versus sham TMS (F(1,869)=5.00, p=.03), but
no main effect for TMS device settings (F(4,51.9)=0.12, ns) nor a pre-post × real-sham ×
device-parameter interaction (F(4,834)=2.21, p=.07; see Table 2).
Cold Pain Thresholds
There were no baseline differences between real versus sham TMS (F(1,409)=0.45, ns), nor
for TMS device setting conditions (F(1,60.9)=0.57, ns). There was no main effect for real
versus sham TMS on cold pain thresholds (F(1,867)=0.18, ns), nor for the TMS device
setting factor (F(1,870)=15.33, p<.0001), but no main effect for real versus sham TMS
(F(1,873)=0.22, ns), nor for TMS condition (F(4,62.8)=0.72, ns). There was a significant
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pre-post × real-sham × device-parameter interaction (F(4,864)=3.65, p=.01). Relative to
sham TMS, there were an anti-hyperalgesic effects for 10Hz100% TMS (t(864)=3.09, p=.
002), 10Hz80% TMS (t(865)=2.50, p=.01), and 1Hz80% TMS (t(864)=3.09, p=.002). A
significant hyperalgesic effect was observed for theta-burst TMS (t(864)=2.47, p=.01). No
significant effects were observed the other TMS settings (see Table 2).
Mechanical Pain Thresholds
There was a significant baseline difference in mechanical pain threshold between the real
and sham conditions (F(1,234)=5.56, p=.02) but no difference across the TMS device
parameters (F(4,33)=0.19, ns). After controlling for baseline differences, there was no main
effect for real versus sham TMS (F(1,501)=0.09, ns), nor for TMS device-parameter
condition (F(4,61)=0.12, ns). There was no significant pre-post X real-sham X device-
parameter interaction effect on mechanical pain thresholds (F(4,466)=1.32, ns; see Table 2).
Suprathreshold Magnitude Estimation - Intensity
There were no significant differences between real and sham TMS conditions in baseline
suprathreshold pain intensity ratings (F(1,1022)=3.08, ns), nor across TMS device settings
(F(4,60.9)=0.28, ns). There were no main effects on the pre- post- TMS changes in intensity
ratings between real and sham TMS conditions (F(1,2058)=2.31, ns), nor across TMS device
setting conditions (F(4,62.5)=0.25, ns). There was also no pre-post X real-sham X device-
parameter interaction effect (F(4,2053)=1.98, ns; see Table 2).
Suprathreshold Magnitude Estimation - Unpleasantness
There was a significant baseline difference in suprathreshold pain unpleasantness ratings
between the real and sham conditions (F(1,1023)=16.31, p<.0001), but not across TMS
device setting conditions (F(4,60.9)=0.25, ns). After controlling for baseline differences,
there were no significant main effects on the pre-post- TMS changes in unpleasantness
ratings for the real/sham condition (F(1,2074)=1.34, ns) nor for the TMS device settings
condition (F(4,58.3)=0.16, ns). However, after controlling for baseline differences, the pre-
post X real-sham X device-parameter interaction was significant (F(4,2044)=5.08, p=.0004).
There was a significant analgesic effect for 10Hz100% TMS on unpleasantness ratings
(t(2043)=2.08, p=.038) and for 1Hz80% (t(2041)=2.28, p=.023). There were no significant
effects observed for other TMS device settings (see Table 2).
Wind-up Pain
Because all wind-up slope measurements were forced to start with a score of 0 for all
conditions, baseline differences were not examined. There was no main effect for real versus
sham TMS (F(1,19000)=2.02, ns), nor for TMS condition (F(4,63)=1.02, ns). There was a
significant three-way pre-post X real-sham X device-parameter interaction effect on wind-
up slopes (F(4,19000)=4.27, p=.002).
Real TMS at 10Hz80% was associated with a significant decrease in wind-up slope relative
to sham (t(19000)=11.34, p<.0001) as was 1Hz80% (t(19000)=11.43, p<.0001). Real
10Hz100% TMS was associated with a significant increase in wind-up slope
(t(19000)=7.42, p<.0001) compared to sham as was theta-burst TMS (t(19000)=4.68, p<.
0001) suggesting hyperalgesic effects for these two settings (see Table 2).
Discussion
Findings from this randomized, sham-controlled trial wherein the procedural sensations of
real TMS were matched between sham and real conditions suggest that the effects of motor
cortex TMS on laboratory-induced pain in healthy adults are small and variable. Overall,
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forty minutes of active motor cortex TMS was associated with significant effects on heat
sensory thresholds, cold sensory thresholds, cold pain thresholds, suprathreshold thermal
stimulus unpleasantness ratings and wind-up pain. No significant effects were observed for
suprathreshold thermal stimulus intensity ratings, heat pain thresholds, or mechanical pain
thresholds. Device-parameter specific effects were found for several of the QST measures.
10Hz stimulation (regardless of intensity) was associated with a total of 7 significant
analgesic effects, anti-hyperalgesic effects, and/or decreased sensitivity to non-noxious
stimuli in the present study, and only 1 hyperalgesic effect. 1Hz stimulation was associated
with a total of 4 significant analgesic effects, anti-hyperalgesic effects, and/or decreased
sensitivity to non-noxious stimuli, but no hyperalgesic effects. Theta-burst stimulation was
associated with 2 hyperalgesic effects. In general, these findings are consistent with much of
the available data from several studies suggesting that low-frequency motor rTMS and
intermittent theta-burst may produce no effects or even hyperalgesic effects while higher-
frequency stimulation (e.g., 10–20Hz) is associated with more robust analgesic and/or anti-
sensitivity effects [19,20,32–36,41,43,44]. With respect to stimulus intensity, there did not
appear to be much difference between 100% versus 80% stimulation when collapsing across
frequencies. These findings suggest that some TMS device settings may be better than
others to help manage pain in clinical cohorts (e.g. high frequency), and that some of the
device settings available to practitioners are may be counter-therapeutic (e.g., theta-burst).
Theta-burst TMS effects on pain perception are less studied and not well-understood
compared to the other settings employed in this study, and it should be clarified that theta-
burst differs substantially from the other settings investigated in the present study. There is
some evidence that continuous theta-burst stimulation is associated with cortical inhibition
and analgesic effects, whereas intermittent theta-burst (more like the condition employed in
the present study) is not [53] [54]. Findings from the present study seem to support this.
More work is needed to clarify the effects of continuous and intermittent theta-burst
stimulation on pain perception.
With respect to mechanisms of motor TMS action on pain perception, there is some
evidence that changes in activity at local cortical sites as well as at the thalamic nuclei may
be involved[42]. It is possible that corticothalamic tracts may exert an inhibitory influence
on thalamic pain processing and transmission [29]. High frequency rTMS may suppress pain
information relayed through the spinothalamic tracts and the ipsilateral thalamic nuclei
[33,36,37]. However, there is also evidence to suggest that at least a portion of motor-cortex
TMS-related analgesic effects may be due to changes in prefrontal and limbic activity
[33,34,43]. The present study did not directly address the issue of mechanisms per se, but
overall, the data seem to support the notion that higher frequency stimulation is generally
associated with more suppression of spinothalamic tract activity than low frequency
stimulation. Thus, differences between device settings with respect to hyperalgesic versus
analgesic effects may be related to the interaction between TMS frequency and
corticothalamic tract activity patterns. But, the presence of a motor TMS effect on
suprathreshold unpleasantness ratings, and not on intensity ratings suggests that there may
have been a TMS-related influence exerted on the processing of the emotional component of
the pain experience. While 10Hz100% motor TMS was associated with mostly analgesic,
anti-hyperalgesic, and decreased sensitivity effects, a hyperalgesic effect was observed for it
on our wind-up pain measure. The nature of this finding is unclear, but may suggest that
10Hz100% TMS over the motor cortex ipsilateral to the side of repetitive noxious
stimulation has little impact (or even counter-therapeutic effects) on receptive field
expansion of wide-dynamic range neurons in the spinal cord (primarily a central pain
facilitation/sensitization process). We might then speculate that 10Hz100% motor TMS
produces analgesic effects by enhancing cortical inhibitory processes at the expense of
resources that might otherwise be used to dampen central sensitization.
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Synchronization and desynchronization of the neural patterns may play a role in perception,
motor action and conscious experience [55], and it has been suggested that human rolandic
oscillations originate in the anterior bank of the central sulcus (20-Hz rhythm) and the
postcentral cortex (10-Hz rhythm). Tamura et al [55] found that 1-Hz rTMS over motor
cortex significantly reduced movement-related rebound of the 20-Hz oscillation in
association with decreased motor cortical excitability. It may be that different TMS
frequencies interact with oscillations associated with different cortical structures and
functions to produce observed effects on pain perception. However, data from the current
study do not permit any inference with respect to such mechanisms of action. More work is
needed in this area.
There are several limitations of current study including the fact that only a healthy adult
cohort was employed. There is evidence that chronic pain of various etiologies is associated
with changes in cortical and subcortical organization that may maintain or exacerbate pain.
The area(s) of aberrant reorganization are potential targets of TMS treatment. Since this
reorganization is not present in healthy adult samples, inferences about optimal device
parameters and hypothetical mechanisms of TMS action may not necessarily be valid for all
clinical applications. However, the findings from this study are consistent with much of the
literature on the use of motor TMS to manage chronic pain as many of these studies have
reported analgesic benefits associated with higher frequency stimulation. Much work is
needed to determine the TMS device parameters (intensity and frequency), as well as
stimulation on and off times, treatment schedules, treatment durations and maintenance
schedules that optimally manage chronic pain of different types.
In the present study, the side of TMS stimulation was the same as the thermal pain target
(i.e., left motor cortex and left volar forearm) but not the mechanical pain target (i.e., right
hand). It is possible that the effect-sizes reported in the present study underestimate the
effects that might be seen when TMS is delivered over the cortex contralaterally to the
painful area (as is typically done in clinical settings). However, there was not a large
discrepancy in the effects observed between hands in the present study (although the
laterality of stimulation is confounded by experimental pain modality). Interestingly,
significant analgesic effects were observed for thermal pain despite the ipsilateral cortical
target supporting the notion that at least a portion of motor-cortex TMS-related analgesic
effects may be due to changes associated with the affective and cognitive-evaluative
dimensions of pain experience [33,34,43].
In summary, findings from this controlled, randomized investigation suggest that the effects
of motor cortex TMS on laboratory-induced pain in healthy adults are small and vary to
some extent as a function of frequency and intensity parameters. Higher frequency
stimulation appears to be associated with the most analgesic effects, anti-hyperalgesic
effects, as well as decreased sensitivity to non-noxious stimuli. These findings are consistent
with several studies using clinical participants which suggest that higher TMS frequencies
tend to be associated with the most clinical benefit [32]. Future work is needed to clarify
mechanisms of action, evaluate the effects of contralateral versus ipsilateral stimulation, and
to determine whether laboratory investigations in healthy adult cohorts are generalizable to
different clinical pain conditions.
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